⌘K

Login Start Free

Home/Filings/4/0001144204-13-016155

4//SEC Filing

Echelard Yann 4

Accession 0001144204-13-016155

CIK 0001001316other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:31 PM ET

Size

5.0 KB

Accession

0001144204-13-016155

Insider Transaction Report

Form 4

Period: 2013-03-15

TG THERAPEUTICS, INC.TGTX

Director

Transactions

Award
COMMON STOCK
2013-03-15+50,000→ 50,000 total

Footnotes (1)

[F1]Reflects a grant of restricted shares that will vest according to the following schedule: 33.3% on November 9, 2015; 33.3% on November 9, 2016; and 33.3% on November 9, 2017.

Documents

1 file

4
v338552_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TG THERAPEUTICS, INC.

CIK 0001001316

Entity typeother

Related Parties

1

filerCIK 0001561958

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 4:31 PM ET
Size: 5.0 KB

View on SEC.gov